Agriculture & Agritech Global On demand · 24-48h

Global Automated DNA Extractor Market Strategic Research Report

Global Automated DNA Extractor Market Strategic Research Rep…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Automated DNA Extractor Market
$2.06B2025
8.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: 4 Channel, 8 Channel, 12 Channel, 96 Channel, 384 Channel

By Application: Medical, Biotechnology, Food, Pharmaceuticals, Forensics, Agriculture and Animal Husbandry, Environment

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Qiagen, Bio-Rad, Bioneer, Infitek, BGI, Roche, Magen Biotech, Lepu Medical, Tiangen Biotech, Mindray, Bruker, Eppendorf, Hangzhou LifeReal Biotechnology, Analytik Jena, Daan Gene, MP Biomedicals, Bioteke Corporation, Ardent BioMed, Macro & Micro-Test, Microgentas, Sansure Biotech, Seegene, Unimed Medical, MegaRobo, NanoString, Precision System Science, ADS Biotec, Blue-Ray Biotech, Bigfish Bio-tech, Kurabo, Biobase, Promega

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 214 pages
Market size 2025
$2.06B
Billion USD
Forecast CAGR
8.3%
2025-2032
Forecast 2032
$3.6B
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Automated DNA Extractor market size is predicted to grow from US$ 2,058 million in 2025 to US$ 3,560 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032.

An automated DNA extractor is a laboratory instrument designed to streamline and standardize the DNA extraction process from various biological samples, including blood, tissues, saliva, and other bodily fluids. These devices significantly reduce the manual labor and time typically associated with DNA extraction, increasing throughput and consistency, which is especially valuable in high-volume labs and clinical settings.

The market for automatic DNA extractors has grown rapidly over the past decade, mainly benefiting from the surge in demand in fields such as genomics, precision medicine and forensics.

Regional market structure:

North America occupies the main global market, mainly due to the concentration of biotechnology companies (such as Thermo Fisher, Bio-Rad) and the widespread application of gene sequencing technology.

The Asia-Pacific region (especially China and Japan) has the fastest growth. China's demand for nucleic acid testing has surged after the epidemic. In 2020, the sales of medical automatic nucleic acid extractors have grown at an accelerated rate. Policy support (such as the "14th Five-Year Plan" bio-economy plan) and medical and health needs are the main driving forces.

Emerging markets such as South America and Africa are gradually growing due to improved medical conditions.

Mainstream technology:

Magnetic bead method occupies the mainstream market and has become the mainstream due to its high efficiency and low pollution characteristics. Representative companies include Qiagen. The equipment integrates functions such as PCR amplification and quantitative analysis, such as Qiagen's QIAcube Connect system

Application field distribution:

Clinical diagnosis occupies the mainstream application field, which is used for pathogen detection, genetic disease screening, etc., and demand has surged during the epidemic.

​Genomic research drives demand, such as cancer genomics, which requires large-scale DNA sample processing.

Forensic medicine requires rapid extraction of trace DNA, and the accuracy of water quality testing in environmental monitoring reaches 98%.

Major manufacturers and competitive landscape:

International giants: Thermo Fisher, Qiagen, Bio-Rad (leading in magnetic rod technology) dominate the global market.

Chinese local companies: BGI, Daan Gene, and Mindray Medical have seized the market through technological innovation.

Future trends:

High throughput and automation: It is expected that high throughput equipment will grow rapidly in 2030, and integrated technology will become the mainstream.

Emerging market potential: India, Brazil and other regions have increased demand due to increased medical investment.

Policy and scientific research drive: Governments of various countries have increased their investment in biotechnology (such as the EU Horizon 2020 plan) to promote industry upgrades.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Automated DNA Extractor market?

What factors are driving Automated DNA Extractor market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Automated DNA Extractor market opportunities vary by end market size?

How does Automated DNA Extractor break out by Type, by Application?

This report presents a comprehensive overview of the global Automated DNA Extractor market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • 4 Channel
  • 8 Channel
  • 12 Channel
  • 96 Channel
  • 384 Channel

Segment by Extraction Method

  • Magnetic Bead Method
  • Centrifugal Column Method
  • Solid Phase Extraction Method

Segment by Application

  • Medical
  • Biotechnology
  • Food
  • Pharmaceuticals
  • Forensics
  • Agriculture and Animal Husbandry
  • Environment

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Automated DNA Extractor market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Medical, Biotechnology, Food evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Automated DNA Extractor Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.06B
2025
Forecast
$3.6B
2032
CAGR
8.3%
2025–2032
영역들
5
global
Key companies
Thermo Fisher ScientificQiagenBio-RadBioneerInfitekBGIRocheMagen Biotech
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
4 Channel8 Channel12 Channel96 Channel384 Channel
By Application
MedicalBiotechnologyFoodPharmaceuticalsForensicsAgriculture and Animal HusbandryEnvironment

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 4 Channel
  • 3.1.3 8 Channel
  • 3.1.4 12 Channel
  • 3.1.5 96 Channel
  • 3.1.6 384 Channel
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Medical
  • 4.1.3 Biotechnology
  • 4.1.4 Food
  • 4.1.5 Pharmaceuticals
  • 4.1.6 Forensics
  • 4.1.7 Agriculture and Animal Husbandry
  • 4.1.8 Environment
  • 4.1.9 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Qiagen
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Bio-Rad
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Bioneer
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Infitek
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 BGI
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Roche
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Magen Biotech
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Lepu Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Tiangen Biotech
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Mindray
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Bruker
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Eppendorf
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Hangzhou LifeReal Biotechnology
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Analytik Jena
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Daan Gene
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 MP Biomedicals
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Bioteke Corporation
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Ardent BioMed
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Macro & Micro-Test
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Microgentas
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Sansure Biotech
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Seegene
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Unimed Medical
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 MegaRobo
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
  • 8.26 NanoString
  • 8.26.1 Company Overview
  • 8.26.2 Key Products & Segments
  • 8.26.3 Financial Performance (2023–2025)
  • 8.26.4 Business Strategy
  • 8.26.5 SWOT Analysis
  • 8.26.6 Strategic Implications (2026–2032)
  • 8.27 Precision System Science
  • 8.27.1 Company Overview
  • 8.27.2 Key Products & Segments
  • 8.27.3 Financial Performance (2023–2025)
  • 8.27.4 Business Strategy
  • 8.27.5 SWOT Analysis
  • 8.27.6 Strategic Implications (2026–2032)
  • 8.28 ADS Biotec
  • 8.28.1 Company Overview
  • 8.28.2 Key Products & Segments
  • 8.28.3 Financial Performance (2023–2025)
  • 8.28.4 Business Strategy
  • 8.28.5 SWOT Analysis
  • 8.28.6 Strategic Implications (2026–2032)
  • 8.29 Blue-Ray Biotech
  • 8.29.1 Company Overview
  • 8.29.2 Key Products & Segments
  • 8.29.3 Financial Performance (2023–2025)
  • 8.29.4 Business Strategy
  • 8.29.5 SWOT Analysis
  • 8.29.6 Strategic Implications (2026–2032)
  • 8.30 Bigfish Bio-tech
  • 8.30.1 Company Overview
  • 8.30.2 Key Products & Segments
  • 8.30.3 Financial Performance (2023–2025)
  • 8.30.4 Business Strategy
  • 8.30.5 SWOT Analysis
  • 8.30.6 Strategic Implications (2026–2032)
  • 8.31 Kurabo
  • 8.31.1 Company Overview
  • 8.31.2 Key Products & Segments
  • 8.31.3 Financial Performance (2023–2025)
  • 8.31.4 Business Strategy
  • 8.31.5 SWOT Analysis
  • 8.31.6 Strategic Implications (2026–2032)
  • 8.32 Biobase
  • 8.32.1 Company Overview
  • 8.32.2 Key Products & Segments
  • 8.32.3 Financial Performance (2023–2025)
  • 8.32.4 Business Strategy
  • 8.32.5 SWOT Analysis
  • 8.32.6 Strategic Implications (2026–2032)
  • 8.33 Promega
  • 8.33.1 Company Overview
  • 8.33.2 Key Products & Segments
  • 8.33.3 Financial Performance (2023–2025)
  • 8.33.4 Business Strategy
  • 8.33.5 SWOT Analysis
  • 8.33.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Automated DNA Extractor market size?
The global Automated DNA Extractor market is estimated at US$ 2.06 billion in 2025 (base year) and is projected to reach US$ 3.56 billion by 2032.
What growth rate is expected for the Automated DNA Extractor market through 2032?
The market is expected to grow at a CAGR of 8.3% from 2026 to 2032, expanding from US$ 2.06 billion in 2025 to US$ 3.56 billion in 2032, roughly 1.7 times its base-year value.
How is Automated DNA Extractor defined?
An automated DNA extractor is a laboratory instrument designed to streamline and standardize the DNA extraction process from various biological samples, including blood, tissues, saliva, and other bodily fluids. These devices significantly reduce the manual labor and time typically associated with DNA extraction, increasing throughput and consistency, which is especially valuable in high-volume labs and clinical settings.
How is the Automated DNA Extractor market segmented by type?
By type, the market is segmented into 4 Channel, 8 Channel, 12 Channel, 96 Channel and 384 Channel.
What are the key applications of Automated DNA Extractor?
Key applications covered include Medical, Biotechnology, Food, Pharmaceuticals, Forensics, Agriculture and Animal Husbandry and Environment.
Which companies are profiled in the Automated DNA Extractor market report?
Key players profiled include Thermo Fisher Scientific, Qiagen, Bio-Rad, Bioneer, Infitek, BGI, Roche and Magen Biotech, among 33 companies covered in total.
What geographies does the Automated DNA Extractor market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Automated DNA Extractor?
Policy support (such as the "14th Five-Year Plan" bio-economy plan) and medical and health needs are the main driving forces.
Who should buy the Automated DNA Extractor market report?
The report is intended for manufacturers and solution providers, distributors and end users in Medical, Biotechnology and Food, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Automated DNA Extractor market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.